FDA Inspection
Medley Pharmaceuticals LimitedMedley Pharmaceuticals Limited – FDA Inspection, Dec 14, 2018
Record Details
This FDA Inspection record concerns Medley Pharmaceuticals Limited, with an inspection on December 14, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · 4603a164-174b-4a55-ba3e-3ca32c2768bf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1154972
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Medley Pharmaceuticals Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 31, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| February 19, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medley Pharmaceuticals Limited
- FDA Inspection 1205651 - 2023-05-19
- FDA Inspection 1098331 - 2019-07-31
- FDA Inspection 973541 - 2016-02-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.